Key statistics
On Friday, Innate Pharma SA (IDDA:MUN) closed at 1.74, 0.00% above its 52-week low of 1.74, set on Nov 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.74 |
---|---|
High | 1.74 |
Low | 1.74 |
Bid | 1.55 |
Offer | 1.77 |
Previous close | 1.74 |
Average volume | 0.00 |
---|---|
Shares outstanding | 80.97m |
Free float | 62.13m |
P/E (TTM) | -- |
Market cap | 140.84m USD |
EPS (TTM) | -0.4517 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 07:05 GMT.
More ▼
Press releases
- Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
- Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences
- Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board
- Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024
- Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors
- Innate Pharma Reports First Half 2024 Business Update and Financial Results
- Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024
- Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update
- Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference
More ▼